A Phase III Confirmatory Study of K-237

Last Update Posted : July 1, 2022

Primary Completion: September 30　→　December 31, 2022 [Anticipated]
Study Completion: September 30　→　December 31, 2022 [Anticipated]


Drug: K-237 0.3-0.4mg/kg (once daily)
Ivermectin 3mg tablet
Other Name: Ivermectin 0.3-0.4mg/kg (once daily)
https://clinicaltrials.gov/ct2/show/NCT05056883

変更履歴一覧
https://clinicaltrials.gov/ct2/history/NCT05056883